Lead Ischemic Stroke Program

About RapidPulse

RapidPulse is a US-based medical device company targeting the significant unmet need in ischemic stroke treatment. The company has progressed from FDA IDE approval to initiating patient enrollment in a pivotal study, indicating a transition into late-stage clinical development. As a private, pre-revenue entity, its near-term value inflection is tied to the success of this pivotal trial. The company operates in the competitive cardiovascular device sector with a focused team and technology platform.

Therapeutic Areas

Other Acute Ischemic Stroke (Large Vessel Occlusion) Drugs